These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5420434)

  • 21. Fibrinogen in blood and lymph after massive haemorrhage in dogs.
    Leandoer L
    Acta Chir Scand; 1968; 134(7):511-5. PubMed ID: 5731292
    [No Abstract]   [Full Text] [Related]  

  • 22. Urokinase-induced fibrinolysis of 125-I-fibrin. Conditions for first-order activation kinetics, density-gradient separation of split products, and a microassay.
    Ball AP; Day ED
    Thromb Diath Haemorrh; 1970 Dec; 24(3):463-74. PubMed ID: 5503943
    [No Abstract]   [Full Text] [Related]  

  • 23. Mechanism of action of synthetic fibrinolytic compounds.
    Baumgarten W; Priester LI; Stiller DW; Duncan AE
    Thromb Diath Haemorrh; 1970 Dec; 24(3):495-506. PubMed ID: 5503944
    [No Abstract]   [Full Text] [Related]  

  • 24. Separation and estimation split "products" of fibrinogen and fibrin in human serum.
    Niléhn JE
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):487-98. PubMed ID: 4952978
    [No Abstract]   [Full Text] [Related]  

  • 25. Biochemical pharmacology of the fibrinolysin system of the rat. 3. The mechanism of phenformin (1-(beta-phenethyl)-biguanide)-induced fibrinolytic activity.
    Lassman HB; Back N
    J Pharmacol Exp Ther; 1974 May; 189(2):333-43. PubMed ID: 4275233
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro inhibition of streptokinase-induced proteolysis by Trasylol and by epsilon amino caproic acid (EACA).
    Godal HC; Theodor I
    Scand J Clin Lab Invest; 1965; 17():Suppl 84:199+. PubMed ID: 5295419
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the effect of E-aminocaproic acid on the permeability of capillary vessels].
    Dzizinskiĭ AA; Kochergina TK; Seregina NM
    Farmakol Toksikol; 1968; 31(4):425-6. PubMed ID: 5698132
    [No Abstract]   [Full Text] [Related]  

  • 28. [On the mechanism of action of protamine-sulfate on some indices of blood coagulation system].
    Skipetrov VP
    Farmakol Toksikol; 1966; 29(2):188-92. PubMed ID: 6000344
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental investigations with proteinase inhibitors.
    Nordström S; Blombäck M; Olsson P; Zetterqvist E
    Acta Chir Scand Suppl; 1967; 378():33-40. PubMed ID: 5300105
    [No Abstract]   [Full Text] [Related]  

  • 30. 4-aminomethylbicyclo[2.2.2]-octane-1-carboxylic acid a new potent antifibrinolytic agent. Its evaluation by in vitro assay procedures.
    Baumgarten W; Priester LI; Stiller DW; Duncan AE; Ciminera JL; Loeffler LJ
    Thromb Diath Haemorrh; 1969 Nov; 22(2):263-72. PubMed ID: 5380948
    [No Abstract]   [Full Text] [Related]  

  • 31. [On the effect of a new synthetic inhibitor of the fibrinolytic system].
    Fischer M; Pavlu C
    Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440
    [No Abstract]   [Full Text] [Related]  

  • 32. [Acute defibrination states: mechanism and therapeutic orientation].
    Soulier JP
    Anesth Analg (Paris); 1967; 24(5):485-9. PubMed ID: 5593936
    [No Abstract]   [Full Text] [Related]  

  • 33. Clot lysis in a perfusion system.
    Bouvier CA; Gruendlinger J; Berthoud S
    Thromb Diath Haemorrh; 1966 Jan; 15(1):205-19. PubMed ID: 5919801
    [No Abstract]   [Full Text] [Related]  

  • 34. The in-vivo-effect of E-aminocaproic acid (EACA) on human plasma fibrinolytic system.
    Niewiarowski S; Wolosowicz N
    Thromb Diath Haemorrh; 1966 May; 15(3):491-500. PubMed ID: 4865186
    [No Abstract]   [Full Text] [Related]  

  • 35. The thrombolytic activity of streptokinase in the rabbit.
    English PD; Smith RA; Dupe RJ; Green J; Hibbs MJ
    Thromb Haemost; 1981 Aug; 46(2):535-7. PubMed ID: 7302893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coagulation and fibrinolysis in blood and lymph after massive haemorrhage in dogs.
    Leandoer L
    Acta Chir Scand; 1968; 134(8):597-605. PubMed ID: 5713444
    [No Abstract]   [Full Text] [Related]  

  • 37. Fibrinolytic activity of the vitreous body.
    Forrester JV; Prentice CR; Williamson J; Forbes CD
    Invest Ophthalmol; 1974 Nov; 13(11):875-9. PubMed ID: 4279343
    [No Abstract]   [Full Text] [Related]  

  • 38. Metabolism and distribution of fibrinogen. II. Fibrinogen turnover in polycythaemia, thrombocytosis, haemophilia A, congenital afibrinogenaemia and during streptokinase therapy.
    Tytgat GN; Collen D; Vermylen J
    Br J Haematol; 1972 Jun; 22(6):701-17. PubMed ID: 5037874
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of streptokinase on fibrinogen and related proteins in plasma.
    Bowie LJ; Kinney R; Vye M; Eckert B; Kwaan HC
    Clin Chem; 1986 Jan; 32(1 Pt 1):67-70. PubMed ID: 3940737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.